Significant Agreements and Contracts - Asset Purchase Agreement with Aardvark Therapeutics, Inc. - Additional Information (Details) - Asset Purchase Agreement with Aadvark Therapeutics, Inc. $ in Millions	1 Months Ended
	Apr. 30, 2021 USD ($) shares
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Up-front license fee | $	$ 5.0
Stock consideration value | shares	616,655